3-(2,2,2-trimethylhydrazine)propionate has been researched along with nifedipine in 1 studies
Studies (3-(2,2,2-trimethylhydrazine)propionate) | Trials (3-(2,2,2-trimethylhydrazine)propionate) | Recent Studies (post-2010) (3-(2,2,2-trimethylhydrazine)propionate) | Studies (nifedipine) | Trials (nifedipine) | Recent Studies (post-2010) (nifedipine) |
---|---|---|---|---|---|
251 | 35 | 105 | 16,024 | 2,496 | 1,505 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, Y; Kirimoto, T; Matsuura, N; Miyake, H; Tajima, K | 1 |
1 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and nifedipine
Article | Year |
---|---|
Cardioprotective effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on cardiac dysfunction induced by ischemia/reperfusion in isolated rat hearts.
Topics: Animals; Carnitine; Enzyme Inhibitors; gamma-Butyrobetaine Dioxygenase; Heart Function Tests; Hemodynamics; In Vitro Techniques; Lactic Acid; Male; Methylhydrazines; Mixed Function Oxygenases; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Nifedipine; Rats; Rats, Sprague-Dawley; Ventricular Fibrillation | 2000 |